HHS Announces $1.3 Billion in Funding to States for Bioterrorism Preparedness


WASHINGTON, D.C. --  HHS Secretary Mike Leavitt today announced that the department has made available another $1.3 billion to the states, territories and four metropolitan areas to help strengthen their capacity to respond to terrorism and other public health emergencies.


"Our ability to respond effectively to public health emergencies is an important part of securing our Homeland," Leavitt said.  "These funds will help us build on the progress we have made the past three years with our state and local partners, and will result in a stronger system to care for Americans in emergencies, whether it be a bioterror attack or an infectious disease outbreak like SARS or West Nile virus."


The funds will be used to upgrade infectious disease surveillance and investigation, enhance the readiness of hospitals and the healthcare system to deal with large numbers of casualties, expand public health laboratory and communications capacities and improve connectivity between hospitals, and city, local and state health departments to enhance disease reporting. These emergency preparedness and response efforts are intended to support the National Response Plan and the interim National Preparedness Goal.


The HHS funding is awarded via two separate but interrelated cooperative agreements. HHS' Centers for Disease Control and Prevention (CDC) is providing $862.8 million for strengthening public health preparedness to address bioterrorism, outbreaks of infectious diseases and public health emergencies. It focuses on the critical tasks necessary for the public health community to prepare for and respond to a terrorist event or other public health emergencies, emphasizing integrated response systems.  The ability to quickly and effectively distribute preventative medication in affected areas is one of the nation's top priorities to be addressed.


This year, the CDC may increase the number of state laboratories with certified Level One capability for testing chemical agents. Currently there are CDC-certified laboratories to assist with chemical testing in California, Michigan, New Mexico, New York and Virginia. Other states will be able to submit applications for evaluation and up to five more may be selected for this program. The goal is to insure chemical samples are able to reach a laboratory for analysis within eight hours.


HHS will provide resources for the Early Warning Infectious Disease

Surveillance program within the CDC funding specifically for states bordering

Canada and Mexico (including the Great Lakes States) for the development and

implementation of a program to provide effective detection, investigation and

reporting of urgent infectious disease case reports in the border regions of

the three nations. States included in this program are Alaska, Arizona,

California, Idaho, Indiana, Illinois, Maine, Michigan, Minnesota, Montana, New

Hampshire, New Mexico, New York, North Dakota, Ohio, Pennsylvania, Texas,

Vermont, Washington, and Wisconsin.


Targeted funding to continue the Cities Readiness Initiative (CRI) in the

21 pilot cities will be provided to the states in the CDC grants. The goal is

to ensure the selected cities are prepared to provide oral medications during

a public health emergency to 100 percent of their affected populations. This

entails enhancing each city's dispensing plans with trained staff and

developing plans to augment with federal resources and alternative means of

delivery. The initial funding for CRI focused primarily on the first 21 CRI

cities. This year, CDC is expanding funding by $10 million for the first 21

cities for use in their metropolitan statistical area regardless of state

lines. The CRI program funds will go to the following: Arizona (Phoenix); California (San Diego & San Francisco); Chicago;

Colorado (Denver); Florida (Miami); Georgia (Atlanta); Los Angeles;

Massachusetts (Boston); Michigan (Detroit); Minnesota (Minneapolis); Missouri

(St. Louis); Nevada (Las Vegas); New York City; Ohio (Cleveland); Pennsylvania

(Philadelphia & Pittsburgh); Texas (Dallas & Houston); Washington (Seattle);

and Washington D.C. (the National Capitol Region including parts of Maryland

and Virginia). In addition to the 21 pilot cities, the CDC will expand the CRI program to 15 other metropolitan areas in 15 states. In each case, the funds will go to the

state with the core city of the metropolitan area. Those starting the CRI

program are:


     Riverside-San Bernadino-Ontario, Sacramento-Arden-Arcade-Roseville, and

      San Jose-Sunnyvale-Santa Clara (California);

     Tampa-St. Petersburg-Clearwater and Orlando (Florida);

     Indianapolis (Indiana);

     Kansas City (Missouri);

     Columbus and Cincinnati-Middletown (Ohio);

     Portland-Vancouver-Beaverton (Oregon);

     Providence-New Bedford-Fall River (Rhode Island);

     San Antonio (Texas);

     Virginia Beach-Norfolk-Newport News (Virginia); and

     Milwaukee-Waukesha-West Allis (Wisconsin).


HHS' Health Resources and Services Administration (HRSA) is providing $471

million for states to develop surge capacity to deal with mass casualty

events. This includes the expansion of hospital beds, development of isolation

capacity, identifying additional health care personnel, establishing hospital-

based pharmaceutical caches, and providing mental health services, trauma and

burn care, communications and personal protective equipment. Hospitals play a

critical role in both identifying and responding to any potential terrorism

attack or infectious disease outbreak.


Last year, HHS provided a total $1.3 billion to the states, territories

and four major metropolitan areas for these preparedness activities.


Source: U.S. Department of Health and Human Services

Related Videos
NFID Medical Director, Robert H. Hopkins, Jr., MD  (Photo courtesy by Evoke Kyne)
Shelley Summerlin-Long, MPH, MSW, BSN, RN, senior quality improvement leader, infection prevention, UNC Medical Center, Chapel Hill, North Carolina
Infection Control Today Infection Intel: Staying Ahead with Company updates and product Innovations.
An eye instrument holding an intraocular lens for cataract surgery. How to clean and sterilize it appropriately?   (Adobe Stock 417326809By Mohammed)
Christopher Reid, PhD  (Photo courtesy of Christopher Reid, PhD)
Paper with words antimicrobial resistance (AMR) and glasses.   (Adobe Stock 126570978 by Vitalii Vodolazskyi)
3D illustration: Candida auris   (Adobe Stock 635576411 By Niamh )
 MIS-C (Adobe Stock 350657530 by Bernard Chantal)
Set of white bottles with cleaning liquids on the white background. (Adobe Stock 6338071172112 by zolnierek)
Related Content